Literature DB >> 21696348

Nanodrug delivery systems in dentistry: a review on current status and future perspectives.

Apathsakayan Renugalakshmi1, Thilla Sekar Vinothkumar, Deivanayagam Kandaswamy.   

Abstract

The present review provides an insight into various potential areas of dentistry that are being invaded by nanotechnology based drugs and drug delivery systems. Current treatments for diseases of dental and oral structures rely on the use of classical pharmacological agents which, in some cases are limited by low efficacy and lack of selectivity to target cells. However, various nanostructures in drug delivery and their challenges in the field of dentistry have not been reviewed so far in the literature. The different treatment opportunities of importance include caries control restorations, tooth remineralisation, management of dentinal hypersensitivity, dental caries vaccine, management of oral biofilm, root canal disinfection, local anaesthesia and periodontal infection. The authors have also identified few dental applications demanding extensive research to emerge as a promising therapeutic strategy. We conclude by claiming that dentistry should follow the trend of probing matter at nanoscale to achieve a predictable treatment outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21696348     DOI: 10.2174/156720111796642336

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  4 in total

1.  Biologically Relevant Micellar Nanocarrier Systems for Drug Encapsulation and Functionalization of Metallic Nanoparticles.

Authors:  Victoria Valdivia; Raúl Gimeno-Ferrero; Manuel Pernia Leal; Chiara Paggiaro; Ana María Fernández-Romero; María Luisa González-Rodríguez; Inmaculada Fernández
Journal:  Nanomaterials (Basel)       Date:  2022-05-20       Impact factor: 5.719

2.  Plasma concentration of metformin and dexamethasone after administration through Osseogate.

Authors:  Hong-Kyun Kim; Young-Seok Park
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.

Authors:  Meng Lei; Guanglan Ma; Sijia Sha; Xueyuan Wang; Haiting Feng; Yongqiang Zhu; Xiao Du
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 4.  Iontophoretic Drug Delivery in the Oral Cavity.

Authors:  Apipa Wanasathop; S Kevin Li
Journal:  Pharmaceutics       Date:  2018-08-07       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.